{
  "docId": "019de074-48ca-708b-9817-9b094467f30f",
  "docSlug": "b3581031b12373a5077a05b88a8907f5",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 45,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "key_messages",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "The slide uses a three-column layout to present clinical data for three distinct drug combinations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-48ca-708b-9817-9b094467f30f/25",
  "deckHref": "/decks/019de074-48ca-708b-9817-9b094467f30f",
  "deckJsonHref": "/decks/019de074-48ca-708b-9817-9b094467f30f.json",
  "deckAnchorHref": "/decks/019de074-48ca-708b-9817-9b094467f30f#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.04,
        "y": 0.6
      },
      "kind": "chart",
      "text": "Composite endpoint: CV deaths and HF events",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fcc91d7-df95-4855-adee-fcaa22cbfe9c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.36,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Body weight and Urinary albumin: creatinine ratio",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c50162b-98bb-4987-ace5-60ff70d4379e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.68,
        "y": 0.58
      },
      "kind": "chart",
      "text": "LSM Change (mm Hg) over Trial Day",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "304ef115-2a6f-4068-b93d-bcb9f0e80e88",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.94,
        "x": 0.03,
        "y": 0.93
      },
      "kind": "disclaimer",
      "text": "Epidemiology numbers reflect diagnosed US patients. 1. Jens de Wouw et al. Front. Physiol., 04 September 2019 Sec. Clinical and Translational Physiology Volume 10 – 2019. 2. CKD Prevalence by hypertension status and year, NHANES, ~25-30% of adults diagnosed with hypertension have CKD. LCM = lifecycle management; LoE = loss of exclusivity; CKD = chronic kidney disease; HF = heart failure; MRM = mineralocorticoid receptor modulator; MRAs = mineralocorticoid receptor antagonists; CI = confidence interval; MPO = myeloperoxidase inhibitor; uACR = urinary albumin to creatinine ratio; ETA = active endothelin A; HTN = hypertension; ASI = aldosterone synthase inhibitor; sBP = systolic blood pressure. CinCor acquisition remains subject to customary external clearances; all clinical development plans mentioned herein subject to deal closure.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a432e638-7d59-4ce7-9fbc-9643ecc0c6f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Combinations trials to sustain revenue post Farxiga LoE",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "71bdb2c3-ce10-444b-8971-810d68515cd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.63,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "BioPharmaceuticals: R&D highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3aaab7f-0000-4c22-8252-91fae9d34318",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "7319c6a1-4f6f-4c9d-8e71-c40158eb513d",
      "evidence": "chart/bar-vertical: Body weight and Urinary albumin: creatinine ratio",
      "confidence": 0.5
    },
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "599d7ba7-a72e-423e-a2be-de63c78c450c",
      "evidence": "chart/line: LSM Change (mm Hg) over Trial Day",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}